Kathryn E Falberg Arcus Biosciences, Inc. (RCUS) insider trading activity

Kathryn E Falberg is Director of Arcus Biosciences, Inc.. Currently has a direct ownership of 68,600 shares of RCUS, which is worth approximately $646,212. The most recent transaction as insider was on Jun 10, 2025, when has been sold 13,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.6K

24.05% 3M change

24.05% 12M change

Total Value Held $646,212

KATHRYN E FALBERG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 10 2025	BUY Grant, award, or other acquisition	-	13,300 Added 16.24%	68,600 Common Stock
Jun 06 2024	BUY Grant, award, or other acquisition	-	8,400 Added 13.19%	55,300 Common Stock
Jun 15 2023	SELL Bona fide gift	-	50,504 Reduced 55.74%	40,100 Common Stock
Jun 15 2023	BUY Grant, award, or other acquisition	-	6,800 Added 12.66%	46,900 Common Stock
Jun 14 2022	BUY Grant, award, or other acquisition	-	4,100 Added 4.33%	90,604 Common Stock
Jun 03 2021	BUY Grant, award, or other acquisition	-	3,000 Added 3.35%	86,504 Common Stock

Also insider at

TTD

Trade Desk, Inc. Technology

Director

NUVB

Nuvation Bio Inc. Healthcare

TCDA

Tricida, Inc. Healthcare

Director

URGN

UroGen Pharma Ltd. Healthcare

Director

KEF